Effects of Alum Adjuvant or a Booster Dose on Immunogenicity during Clinical Trials of Group B Streptococcal Type III Conjugate Vaccines

Phase 1 and 2 clinical trials of group B streptococcal (GBS) capsular polysaccharide (CPS)-protein conjugate vaccines in healthy adults have demonstrated their safety and improved immunogenicity compared with uncoupled CPSs. Two recent trials sought to determine (i) whether adsorption of conjugate v...

Popoln opis

Bibliografske podrobnosti

izdano v:	Infect Immun
Principais autores:	Paoletti, L. C., Rench, M. A., Kasper, D. L., Molrine, D., Ambrosino, D., Baker, C. J.
Format:	Artigo
Jezik:	Inglês
Izdano:	American Society for Microbiology (ASM) 2001
Teme:	Microbial Immunity and Vaccines
Online dostop:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC100045/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11598040/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/IAI.69.11.6696-6701.2001
Oznake:	Označite Brez oznak, prvi označite!